Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967667 · ClinicalTrials.gov registry record · NA
Biological Evaluation of Dietary Supplement Liposomal Glutathione
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01967667 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 11 participants.
The verdict
NCT01967667, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Low levels of antioxidant molecules such as glutathione have been found in people with a diagnosis of schizophrenia. However, oral glutathione is not well absorbed because the compound is mostly broken down in the gastrointestinal system. Liposomes are tiny droplets of oil particles that encapsulate and protect the glutathione. In this study we will evaluate a liposomal formulation of glutathione for tolerability and to examine if this formulation serves the function of increasing glutathione in the brain and body.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Liposomal glutathione
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-04 |
| Est. Completion | 2021-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01967667
The ClinicalTrials.gov registry entry for NCT01967667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01967667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01967667 about?
NCT01967667 is a clinical study titled "Biological Evaluation of Dietary Supplement Liposomal Glutathione". Low levels of antioxidant molecules such as glutathione have been found in people with a diagnosis of schizophrenia. However, oral glutathione is not well absorbed because the compound is mostly broken down in the gastrointestinal system. Liposomes are tiny droplets of oil particles that encapsulate...
What is the current status of trial NCT01967667?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-04. Estimated completion is 2021-02.
What interventions are being tested in trial NCT01967667?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Liposomal glutathione (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01967667?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.